|Podcasts|February 7, 2023
The Rewarding Path Of Science
Author(s)Lisa Henderson, Andy Studna, Senior Editor
Dr. Sean Bohen, CEO of Olema Oncology, discusses his career and significant contributions to the clinical research and development of numerous oncology drugs that received regulatory approval for various indications. Plus a look at Olema, how they operate, and challenges they face.
Related Content
Trending on Applied Clinical Trials Online
1
Why Real-World Evidence Can No Longer Wait Until After Approval
2
Three Tensions Transforming Clinical Operations Excellence
3
ACT Brief: Process Architecture Over Autonomous AI, Real-Time RWE Integration, and Building RWE Infrastructure
4
SCOPE X: The COPD Case Study That Shows What AI Can Do for Enrollment
5